Yilmaz, Ahmet
Cui, Hanwei
Caligiuri, Michael A.
Yu, Jianhua
Funding for this research was provided by:
National Institutes of Health (AI129582, CA247550, NS106170, CA223400, CA210087, CA068458, CA163205)
Article History
Received: 16 September 2020
Accepted: 12 November 2020
First Online: 7 December 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: M.A. Caligiuri and J. Yu are the co-founders of CytoImmune Therapeutics, Inc. The other authors declare no competing interests.